This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Davis, B. H. Articles by Madri, J. A. Search for Related Content PubMed PubMed Citation Articles by Davis, B. H. Articles by Madri, J. A.

American Journal of Pathology, Vol 126, 137-147, Copyright © 1987 by American Society for Investigative Pathology

REGULAR ARTICLES

Type I and type III procollagen peptides during hepatic fibrogenesis. An immunohistochemical and ELISA serum study in the CCl4 rat model

BH Davis and JA Madri

Serum assays of procollagen peptides have been suggested as useful clinical indicators of hepatic fibrogenesis. To evaluate these assays in an experimental situation, the carbon tetrachloride model of hepatic fibrosis was produced in the rat. With affinity-purified antibodies, ELISA assays were developed and used for detecting nanogram quantities of the aminopropeptides of Types I and III procollagen (pro-I and pro- III) in rat serum. Serum SGPT levels were also determined. Routine histologic staining, as well as immunofluorescent staining for localization of Types I, III, and IV collagen and the aminopropeptides of Types I and III procollagen were performed on corresponding livers. It was found that serum pro-III levels were elevated after 45 and 70 days of treatment (28 +/- 15.2 ng/ml and 21 +/- 3.4 ng/ml, respectively) but returned to normal levels after 90 days of treatment (less than 3 ng/ml). Serum pro-I levels were elevated after 45 days of treatment (1028 +/- 504 ng/ml) but were normal at 70 and 90 days of treatment. Serum SGPT values were elevated at 45 and 70 days of treatment but were normal at 90 days of treatment. The decline in serum pro-III levels appeared to parallel the noted decline in SGPT values. Linear regression analysis revealed a good correlation between pro-III levels and histologic inflammation (r = 0.886) but a poor correlation between pro-III levels and histologic fibrosis (r = 0.116). Immunohistochemistry revealed that the pro-III antigen persists extracellularly for at least 45 days. Therefore, serum assays of pro- III might reflect extracellular collagen degradation as well as active collagen secretion. This would limit the clinical utility of the pro- III assay as an unequivocal marker of active hepatic collagen deposition.

This article has been cited by other articles:

				G. Son, Y. Iimuro, E. Seki, T. Hirano, Y. Kaneda, and J. Fujimoto Selective inactivation of NF-{kappa}B in the liver using NF-{kappa}B decoy suppresses CCl4-induced liver injury and fibrosis Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G631 - G639. [Abstract] [Full Text] [PDF]

				E. Gaudio, B. Barbaro, D. Alvaro, S. Glaser, H. Francis, A. Franchitto, P. Onori, Y. Ueno, M. Marzioni, G. Fava, et al. Administration of r-VEGF-A prevents hepatic artery ligation-induced bile duct damage in bile duct ligated rats Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G307 - G317. [Abstract] [Full Text] [PDF]